2011 annual financial data
Fate Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,038.03%.
Operating income was -13,293,000 USD and net income was -13,427,000 USD.
Operating cash flow was -12,145,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,170,000 USD
- Operating income
- -13,293,000 USD
- Net income
- -13,427,000 USD
- Operating cash flow
- -12,145,000 USD